Young-Adult viewership soars as HBCU Honors defies trends with major gains; expanded long-form now streaming on HBCU Honors YouTube. WASHINGTON, DC, UNITED STATES, December 31, 2025 /EINPresswire.com/ ...
PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) (the “Company” or “PharmaTher”) today announced that CEO Fabio Chianelli has published ...
Proceeds to Support the Company’s Assessment of Opportunities to Advance BX011 and Ongoing Evaluation of Strategic ...
Written feedback from FDA pre-NDA meeting includes a recommendation to conduct a second Phase 3 trial to generate additional ...
Continuing its journey of giving throughout 2025 through innovative initiatives aligned with Kuwait Vision 2035 ...
KELOWNA, BC / / December 30, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a ...
Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with ...
We are excited to share this progress which would not have been possible without the study participants and their caregivers, investigators and site staff, and all who have contributed to the ...
Contract Research Organization for the REGAL trial has informed the Company that 72 events have occurred in the trial as of December 26, 2025; SELLAS remains blinded to trial outcomesTiming of the fin ...
The 2025 World Humanoid Robot Games demonstrated the appeal of combining technology with sports. Experts predict that ...
Good afternoon, ladies and gentlemen, and welcome to the Good Times Restaurants Inc. Fiscal 2025 Fourth Quarter and Year-end Earnings Call. I am Keri August, the company's Senior Vice President of ...
18hon MSN
HELUS Pharma Propels Therapeutic Innovation in Mental Health and Commences Trading on Nasdaq
BOSTON & TORONTO--(BUSINESS WIRE)-- Cybin Inc. (the “Company”) doing business as Helus Pharma™ (Nasdaq: HELP) (Cboe CA: HELP) (“Helus Pharma”), a clinical stage pharmaceutical company committed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results